Biotechnology Stocks I Performance Guide: Akero Therapeutics, Inc. (AKRO)
AKRO has no dividends.
Table and Chart of AKRO Performance
See what a $1,000 investment in AKRO is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| AKRO Returns | |
|---|---|
| Start Date | Jul-31-2019 |
| Start Price | $24.20 |
| End Date | May-07-2024 |
| End Price | $22.02 |
| # Prices | 59 |
| Min Date | May-31-2022 |
| Min Price | $8.64 |
| Max Date | Dec-30-2022 |
| Max Price | $54.80 |
| Total Return | -9.01% |
| Annualized Return | -1.90% |
| Current Value of $1,000 Purchase | $910 |
| Number Returns | 1,711 |
| Average Return | 28.43% |
| Number Profitable Returns | 906 |
| Percent Profitable Returns | 52.95% |
| Number Unprofitable Returns | 805 |
| Percent Unprofitable Returns | 47.05% |
| Profitable to Unprofitable Returns Ratio | 1.13 |
| AKRO Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,522,705,000 |
| Beta | -0.384 | Price to Sales |
| Earnings per Share | $-2.8900 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.858 |
| PRICE DATA | |
| 52 Week High | $58.38 |
| 52 Week Low | $11.25 |
| Analyst Target Price | $48.38 |
| 50-Day Moving Average | $24.21 |
| 200-Day Moving Average | $27.97 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -35.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
AKRO Compare Returns with S&P 500
AKRO Trendline Chart
AKRO Moving Average Chart
AKRO Stock Return Map - See Patterns of Gains and Losses
AKRO Stock Returns/Purchase Dates